Neervannan Seshadri 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Neervannan Seshadri
Chief Operating Officer
Transactions
- Gift
Common Stock
2025-12-16−950→ 79,183 total - Gift
Common Stock
2025-12-16+475→ 475 total(indirect: By daughter)
Footnotes (2)
- [F1]Includes 451 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2025.
- [F2]This transaction involved the Reporting Person's gift of 475 shares of common stock to his daughter who shares Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by his daughter, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.